Veterinary medicines in 2024
Submitted by Anonymous (not verified) on 23 January 2025 - 10:55
Veterinary medicines in 2024
PSUSA/00002991/202406
Submitted by Anonymous (not verified) on 23 January 2025 - 10:50
PSUSA/00002991/202406
PSUSA/00001416/202405
Submitted by Anonymous (not verified) on 23 January 2025 - 10:48
PSUSA/00001416/202405
CHMP work plan 2025
Submitted by Anonymous (not verified) on 23 January 2025 - 10:39
CHMP work plan 2025
Procedural advice for orphan medicinal product designation: Guidance for sponsors
Submitted by Anonymous (not verified) on 23 January 2025 - 9:48
Procedural advice for orphan medicinal product designation: Guidance for sponsors
Human medicines European public assessment report (EPAR): Kigabeq, vigabatrin, Date of authorisation: 20/09/2018, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 23 January 2025 - 8:56
Human medicines European public assessment report (EPAR): Kigabeq, vigabatrin, Date of authorisation: 20/09/2018, Revision: 7, Status: Authorised
European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey
Submitted by Anonymous (not verified) on 23 January 2025 - 7:52
European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey
Parallel scientific advice processes and special product types
Submitted by Anonymous (not verified) on 22 January 2025 - 16:41
Parallel scientific advice processes and special product types
PSUSA/00001215/202406
Submitted by Anonymous (not verified) on 22 January 2025 - 16:00
PSUSA/00001215/202406
PSUSA/00000463/202404
Submitted by Anonymous (not verified) on 22 January 2025 - 15:59
PSUSA/00000463/202404